![All lanes : Anti-DTYMK antibody [1G8] (ab124026) at 1/2000 dilutionLane 1 : HEK293T cells transfected with pCMV6-ENTRY control cDNALane 2 : HEK293T cells transfected with pCMV6-ENTRY DTYMK cDNALysates/proteins at 5 µg per lane.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_2/10423_DTYMK-Primary-antibodies-ab124026-1.jpg)
All lanes : Anti-DTYMK antibody [1G8] (ab124026) at 1/2000 dilutionLane 1 : HEK293T cells transfected with pCMV6-ENTRY control cDNALane 2 : HEK293T cells transfected with pCMV6-ENTRY DTYMK cDNALysates/proteins at 5 µg per lane.

ab124026, at 1/150, staining DTYMK in paraffin embedded Human endometrium adenocarcinoma tissue by Immunohistochemistry.

ab124026, at 1/150, staining DTYMK in paraffin embedded Human prostate tissue by Immunohistochemistry.

ab124026, at 1/150, staining DTYMK in paraffin embedded Human bladder carcinoma tissue by Immunohistochemistry.

ab124026, at 1/100, staining DTYMK in COS7 cells transiently transfected with pCMV6-ENTRY DTYMK by Immunofluorescence.

ab124026 at 1/100 dilution staining DTYMK in HEK293T cells transfected with either pCMV6 ENTRY DTYMK (Red) or empty vector control plasmid (Blue) by flow cytometry.